Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Chemocentryx Inc (CCXI)

Chemocentryx Inc (CCXI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,030,905
  • Shares Outstanding, K 69,750
  • Annual Sales, $ 64,890 K
  • Annual Income, $ -55,360 K
  • 60-Month Beta 1.45
  • Price/Sales 16.09
  • Price/Cash Flow N/A
  • Price/Book 2.89
Trade CCXI with:

Options Overview

Details
  • Implied Volatility 91.00%
  • Historical Volatility 61.50%
  • IV Percentile 49%
  • IV Rank 20.71%
  • IV High 254.25% on 06/14/21
  • IV Low 48.35% on 11/30/20
  • Put/Call Vol Ratio 1.66
  • Today's Volume 6,964
  • Volume Avg (30-Day) 7,598
  • Put/Call OI Ratio 0.55
  • Today's Open Interest 102,686
  • Open Int (30-Day) 112,883

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/21
See More
  • Average Estimate -0.55
  • Number of Estimates 6
  • High Estimate -0.51
  • Low Estimate -0.63
  • Prior Year 0.29
  • Growth Rate Est. (year over year) -289.66%

Price Performance

See More
Period Period Low Period High Performance
1-Month
13.20 +18.86%
on 07/06/21
18.14 -13.51%
on 07/12/21
+2.51 (+19.04%)
since 07/02/21
3-Month
9.53 +64.64%
on 05/25/21
18.14 -13.51%
on 07/12/21
-11.80 (-42.92%)
since 05/05/21
52-Week
9.53 +64.64%
on 05/25/21
70.29 -77.68%
on 02/09/21
-39.66 (-71.65%)
since 08/05/20

Most Recent Stories

More News
ChemoCentryx to Participate in the Canaccord Genuity 41st Annual Growth Conference

ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that Thomas J. Schall, Ph.D., President and Chief Executive Officer, will participate in a fireside chat at the Canaccord Genuity 41st Annual Growth...

CCXI : 15.69 (+2.42%)
Analysts Estimate ChemoCentryx (CCXI) to Report a Decline in Earnings: What to Look Out for

ChemoCentryx (CCXI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

CCXI : 15.69 (+2.42%)
ChemoCentryx to Hold Second Quarter 2021 Financial Results Conference Call on Monday, August 9, 2021

ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that the Company's second quarter 2021 financial results will be released after market close on Monday, August 9, 2021. ChemoCentryx executive management...

CCXI : 15.69 (+2.42%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ChemoCentryx, Inc. - CCXI

Pomerantz LLP is investigating claims on behalf of investors of ChemoCentryx, Inc. ("ChemoCentryx" or the "Company") (NASDAQ: CCXI). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com...

CCXI : 15.69 (+2.42%)
Thinking about buying stock in Ashford Hospitality Trust, Bridgeline Digital, Inuvo, Newegg Commerce, or ChemoCentryx?

/PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AHT, BLIN, INUV, NEGG, and CCXI.

INUV : 0.8400 (+4.21%)
BLIN : 5.41 (+1.69%)
CCXI : 15.69 (+2.42%)
NEGG : 20.33 (+22.40%)
AHT : 14.44 (+4.49%)
ChemoCentryx (CCXI) Files Amendment to NDA for Avacopan

ChemoCentryx (CCXI) files an amendment to its NDA for avacopan for treatment of ANCA-associated vasculitis. The new PDUFA date is Oct 7. The filing constitutes a major amendment to the original NDA.

BAYRY : 13.8080 (-6.70%)
CCXI : 15.69 (+2.42%)
CTLT : 122.12 (-0.63%)
BNTX : 404.92 (-2.30%)
(CCXI Long-Term Investor Alert: Did You Acquire ChemoCentryx Before November 26, 2019? Should Management be Held Accountable for Investors Losses?

/PRNewswire/ -- , LLP is investigating potential claims on behalf of ChemoCentryx Inc. ("ChemoCentryx" or the "Company") ( CCXI) against certain of its current and former officers and directors. 

CCXI : 15.69 (+2.42%)
LAWSUITS FILED AGAINST CCXI, UI and PRVB - Jakubowitz Law Pursues Shareholders Claims

NEW YORK, NY / ACCESSWIRE / July 6, 2021 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies who purchased...

CCXI : 15.69 (+2.42%)
UI : 313.77 (-1.23%)
PRVB : 6.60 (+9.63%)
INVESTOR ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Class Action Lawsuits filed on behalf of ARRY, CCXI, PCT, WISH Investors, Lead Plaintiff Deadlines Set

NEW ORLEANS, LA / ACCESSWIRE / July 6, 2021 / Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors of pending deadlines in the following...

ARRY : 13.74 (+2.23%)
CCXI : 15.69 (+2.42%)
PCT : 15.81 (+9.11%)
WISH : 9.98 (+3.85%)
Thinking about buying stock in Clover Health, Transocean, ChemoCentryx, BioHiTech Global, or Welbilt?

/PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for CLOV, RIG, CCXI, BHTG, and WBT.

BHTG : 1.3800 (+1.47%)
CCXI : 15.69 (+2.42%)
CLOV : 8.13 (+2.65%)
RIG : 3.38 (+5.30%)
WBT : 23.22 (+0.48%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

ChemoCentryx, Inc. is a biopharmaceutical company focused on discovering, developing and commercializing orally-administered therapeutics to treat autoimmune diseases, inflammatory disorders and cancer. ChemoCentryx, Inc. is headquartered in Mountain View, California.

See More

Key Turning Points

3rd Resistance Point 17.31
2nd Resistance Point 16.74
1st Resistance Point 16.22
Last Price 15.69
1st Support Level 15.13
2nd Support Level 14.56
3rd Support Level 14.04

See More

52-Week High 70.29
Fibonacci 61.8% 47.08
Fibonacci 50% 39.91
Fibonacci 38.2% 32.74
Last Price 15.69
52-Week Low 9.53

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar